Janet L. Stanford

17.2k total citations · 4 hit papers
194 papers, 12.1k citations indexed

About

Janet L. Stanford is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Janet L. Stanford has authored 194 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Pulmonary and Respiratory Medicine, 46 papers in Genetics and 41 papers in Oncology. Recurrent topics in Janet L. Stanford's work include Prostate Cancer Treatment and Research (99 papers), Prostate Cancer Diagnosis and Treatment (68 papers) and Genetic Associations and Epidemiology (26 papers). Janet L. Stanford is often cited by papers focused on Prostate Cancer Treatment and Research (99 papers), Prostate Cancer Diagnosis and Treatment (68 papers) and Genetic Associations and Epidemiology (26 papers). Janet L. Stanford collaborates with scholars based in United States, South Africa and Netherlands. Janet L. Stanford's co-authors include Elaine A. Ostrander, Peter C. Albertsen, Ann S. Hamilton, Arnold L. Potosky, Ziding Feng, Robert A. Stephenson, Frank D. Gilliland, Richard M. Hoffman, David F. Penson and J. William Eley and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Janet L. Stanford

191 papers receiving 11.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Urinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate Cancer

2000 908 citations Janet L. Stanford, Ziding Feng et al. profile →
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms

2003 731 citations Marilie D. Gammon, Janet B. Schoenberg et al. profile →
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer

2013 681 citations Peter C. Albertsen, Ann S. Hamilton et al. profile →
Prostate Specific Antigen Best Practice Statement: 2009 Update

2009 390 citations Peter C. Albertsen, Oliver Sartor et al. The Journal of Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Janet L. Stanford United States	59	6.1k	2.9k	2.9k	2.1k	1.6k	194	12.1k
Richard M. Hoffman United States	60	4.5k 0.7×	1.9k 0.6×	3.4k 1.2×	1.4k 0.7×	853 0.5×	342	11.9k
Jan Adolfsson Sweden	52	5.1k 0.9×	1.9k 0.6×	2.4k 0.8×	1.2k 0.5×	1.4k 0.9×	246	9.5k
Ann W. Hsing United States	67	4.8k 0.8×	3.8k 1.3×	3.6k 1.2×	3.5k 1.6×	2.3k 1.4×	254	14.8k
Neil Fleshner Canada	71	8.4k 1.4×	4.6k 1.6×	3.4k 1.2×	3.3k 1.6×	2.3k 1.4×	661	16.5k
Henrik Grönberg Sweden	57	5.2k 0.9×	1.1k 0.4×	2.6k 0.9×	3.2k 1.5×	2.5k 1.5×	263	11.6k
Laurence Klotz Canada	71	15.7k 2.6×	4.3k 1.4×	3.5k 1.2×	3.5k 1.7×	2.4k 1.5×	480	20.6k
Pär Stattin Sweden	74	7.0k 1.1×	2.1k 0.7×	5.0k 1.7×	4.9k 2.3×	3.6k 2.2×	419	16.8k
Peter C. Albertsen United States	62	11.3k 1.9×	3.3k 1.1×	3.8k 1.3×	1.4k 0.6×	1.3k 0.8×	241	16.1k
Judd W. Moul United States	77	14.6k 2.4×	3.9k 1.3×	3.9k 1.3×	3.9k 1.8×	3.2k 2.0×	526	20.5k
Matti Hakama Finland	59	2.2k 0.4×	2.0k 0.7×	4.4k 1.5×	1.0k 0.5×	1.0k 0.6×	286	12.0k

Countries citing papers authored by Janet L. Stanford

Since Specialization

Citations

This map shows the geographic impact of Janet L. Stanford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet L. Stanford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet L. Stanford more than expected).

Fields of papers citing papers by Janet L. Stanford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet L. Stanford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet L. Stanford. The network helps show where Janet L. Stanford may publish in the future.

Co-authorship network of co-authors of Janet L. Stanford

This figure shows the co-authorship network connecting the top 25 collaborators of Janet L. Stanford. A scholar is included among the top collaborators of Janet L. Stanford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet L. Stanford. Janet L. Stanford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

FitzGerald, Liesel M., Chol‐Hee Jung, Ee Ming Wong, et al.. (2024). Detection of differentially methylated CpGs between tumour and adjacent benign cells in diagnostic prostate cancer samples. Scientific Reports. 14(1). 1 indexed citations

Ma, Chaoran, Xiaoyu Wang, James Y. Dai, et al.. (2023). Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study. Cancer Epidemiology Biomarkers & Prevention. 32(10). 1436–1443. 2 indexed citations

Dai, James Y., Xiaoyu Wang, Anqi Cheng, et al.. (2018). Vigorous Physical Activity Is Associated with Lower Risk of Metastatic–Lethal Progression in Prostate Cancer and Hypomethylation in the CRACR2A Gene. Cancer Epidemiology Biomarkers & Prevention. 28(2). 258–264. 22 indexed citations

Zhao, Shanshan, Milan S. Geybels, Amy Leonardson, et al.. (2016). Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer. Clinical Cancer Research. 23(1). 311–319. 57 indexed citations

Geybels, Milan S., Jonathan L. Wright, Marina Bibikova, et al.. (2016). Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy. Clinical Epigenetics. 8(1). 97–97. 21 indexed citations

Rubicz, Rohina, Irene M. Shui, Shanshan Zhao, et al.. (2015). Health disparities in prostate cancer: Tumor epigenome profiling in African American vs European American men.

Stott‐Miller, Marni, Shanshan Zhao, Jonathan L. Wright, et al.. (2014). Validation Study of Genes with Hypermethylated Promoter Regions Associated with Prostate Cancer Recurrence. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1331–1339. 30 indexed citations

FitzGerald, Liesel M., Akash Kumar, Evan A. Boyle, et al.. (2013). Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility. Cancer Epidemiology Biomarkers & Prevention. 22(9). 1520–1528. 29 indexed citations

Wright, Jonathan L., Philip D. Hansten, & Janet L. Stanford. (2013). Is digoxin use for cardiovascular disease associated with risk of prostate cancer?. The Prostate. 74(1). 97–102. 16 indexed citations

10.

Kwon, Erika M., Claudia A. Salinas, Suzanne Kolb, et al.. (2011). Genetic Polymorphisms in Inflammation Pathway Genes and Prostate Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 20(5). 923–933. 49 indexed citations

11.

Wright, Jonathan L., Erika M. Kwon, Elaine A. Ostrander, et al.. (2011). Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes. Cancer Epidemiology Biomarkers & Prevention. 20(4). 619–627. 120 indexed citations

12.

Langeberg, Wendy J., Salahaldin A. Tahir, Ziding Feng, et al.. (2010). Association of caveolin‐1 and ‐2 genetic variants and post‐treatment serum caveolin‐1 with prostate cancer risk and outcomes. The Prostate. 70(9). 1020–1035. 13 indexed citations

13.

Penney, Kathryn L., Claudia A. Salinas, Mark M. Pomerantz, et al.. (2009). Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality. Clinical Cancer Research. 15(9). 3223–3230. 42 indexed citations

14.

Foster‐Schubert, Karen E., Jessica Chubak, Bess Sorensen, et al.. (2008). Effect of Exercise on Serum Sex Hormones in Men. Medicine & Science in Sports & Exercise. 40(2). 223–233. 59 indexed citations

15.

Agalliu, Ilir, Miia Suuriniemi, Ludmila Prokunina‐Olsson, et al.. (2008). Evaluation of a variant in the transcription factor 7‐like 2 (TCF7L2) gene and prostate cancer risk in a population‐based study. The Prostate. 68(7). 740–747. 30 indexed citations

16.

Hoffman, Richard M., Michael J. Barry, Janet L. Stanford, et al.. (2006). Health Outcomes in Older Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study. The American Journal of Medicine. 119(5). 418–425. 32 indexed citations

17.

Penson, David F., Dale McLerran, Lin Li, et al.. (2005). 672: Five-Year Urinary and Sexual Outcomes after Watchful Waiting: Results from the Prostate Cancer Outcomes Study. The Journal of Urology. 173(4S). 183–183. 1 indexed citations

18.

Lubieniecka, Joanna M., et al.. (2003). Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population‐based case‐control study. The Prostate. 59(4). 357–359. 12 indexed citations

19.

Britton, Julie A., Marilie D. Gammon, Jennifer L. Kelsey, et al.. (2001). Characteristics Associated with Recent Recreational Exercise Among Women 20 to 44 Years of Age. Women & Health. 31(2-3). 81–96. 14 indexed citations

20.

Nelson, Peter S., Janet L. Stanford, & Elaine A. Ostrander. (2001). Prostate Cancer Research in the Post-Genome Era. Epidemiologic Reviews. 23(1). 187–190. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact